Assessment of an ethanolic seed extract of Picralima nitida ((Stapf) Th. & H. Durand) on reproductive hormones and its safety for use
Lydia Francisca Otoo, George Asumeng Koffuor, Charles Ansah, Kwesi Boadu Mensah, Charles Benneh, Inemesit Okon Ben.
Abstract
Background: Picralima nitida seed extract (PNE) has aphrodisiac and contraceptive effect. Aim: To investigate the effect of PNE on reproductive hormones. Methodology: The size and length of the combs of White leghorn day-old chicks treated with Testosterone (0.5-1.5 mg/kg), Cyproterone (3-30 mg/kg), or PNE (50-500 mg/kg) for 7 days, as well as Cyproterone (10, and 30 mg/kg) on PNE-induced, and PNE (50-500 mg/kg) on Testosterone-induced comb growth, were measured in the Chick Comb Test. The effect of PNE the percentage change in oviduct-chick weight ratio of Rhode Island Red layer day-old chicks treated with 17- β-estradiol (0.1-0.9 µg), PNE (30-300 mg/kg) or vehicle, for 6 days, was determined in the chick uterotrophic assay. Liver and kidney function, was well lipid and haematological profile tests were conducted to assess safety. Results: Seven-day treatment with PNE and testosterone increased significantly (P≤0.01-0.001), while Cyproterone significantly decreased (P≤0.001) comb growth dose-dependently. Qualitatively, testosterone and PNE treatment resulted in relatively brighter red combs. Cyproterone caused significant inhibition (P≤0.001) of both testosterone and PNE-induced comb growth. Co-administration of testosterone and PNE suppressed comb growth significantly (P≤0.001). Administration of 17- β oestradiol and PNE increased (P≤0.001) oviduct-chick weight ratio dose-dependently. No significant changes were observed on assessing liver and kidney function, lipid profile and haematological parameters. Conclusion: PNE exhibits both androgenic (partial testosterone agonist) and estrogenic activity. It has no detrimental effects on the blood, liver, and kidney tissue with prolonged use.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!